Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform

Summary

Northwest Biotherapeutics appointed Dr. Annalisa Jenkins as Strategic Adviser to advance its DCVax personalized immune therapy platform for solid tumor cancers. This is a routine management/personnel announcement with limited material impact.